Study Design of a Phase 3, Randomized, Double-Blind Study of Ublituximab Versus Fingolimod in Children and Adolescents with Relapsing Multiple Sclerosis: ULTIMATE KIDS II

Drug Category: Array
Conference Category: Array
Lead Author: Mok K, et al.
Published Date: 05/02/2026
Download Link: /wp-content/uploads/2026/01/TGTX-ACTRIMS-2026-KIDS-II-Mok.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top